Skip to main content
Premium Trial:

Request an Annual Quote

Three US Agencies Invest $12M in Rice Sequencing


WASHINGTON--Sources told BioInform last month that three US agencies will soon announce a collaborative funding program for rice genome sequencing. The US National Science Foundation, US Department of Energy, and US Department of Agriculture together will provide $4 million a year for three years to support international efforts to sequence rice. According to an administrator from the agriculture department, the funding could contribute to sequencing 10-25 percent of the rice genome. A larger portion of the rice sequence is expected to be completed by projects that are supported by the Japanese Ministry of Agriculture. Japan is considered the world leader in rice genome sequencing.

Officials said the agencies planned to post a request for proposals on the internet in February. Projects that demonstrate links to the international sequencing effort will be given strongest consideration, an administrator told BioInform, adding that projects with private-sector support would also be encouraged to apply for the funding.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.